Inducible serum proteins whose concentrations oscillate between nontolerogenic and tolerogenic levels pose a particular challenge to the maintenance of self-tolerance. Temporal restrictions of intrathymic antigen supply should prevent continuous central tolerization of T cells, in analogy to the spatial limitation imposed by tissue-restricted antigen expression. Major acute-phase proteins such as human C-reactive protein (hCRP) are typical examples for such inducible self-antigens. The circulating concentration of hCRP, which is secreted by hepatocytes, is induced up to 1,000-fold during an acute-phase reaction. We have analyzed tolerance to hCRP expressed in transgenic mice under its autologous regulatory regions. Physiological regulation of basal levels (<10−9 M) and inducibility (>500-fold) are preserved in female transgenics, whereas male transgenics constitutively display induced levels. Surprisingly, crossing of hCRP transgenic mice to two lines of T cell receptor transgenic mice (specific for either a dominant or a subdominant epitope) showed that tolerance is mediated by intrathymic deletion of immature thymocytes, irrespective of widely differing serum levels. In the absence of induction, hCRP expressed by thymic medullary epithelial cells rather than liver-derived hCRP is necessary and sufficient to induce tolerance. Importantly, medullary epithelial cells also express two homologous mouse acute-phase proteins. These results support a physiological role of “ectopic” thymic expression in tolerance induction to acute-phase proteins and possibly other inducible self-antigens and have implications for delineating the relative contributions of central versus peripheral tolerance.
Skip Nav Destination
Article navigation
1 July 1998
Article|
July 01 1998
CD4 T Cell Tolerance to Human C-reactive Protein, an Inducible Serum Protein, Is Mediated by Medullary Thymic Epithelium
Ludger Klein,
Ludger Klein
From the *Tumor Immunology Program, Divison of Cellular Immunology, German Cancer Research Center, D-69120 Heidelberg, Germany; and the ‡Institute for Molecular Biology, Hannover Medical School, D-30625 Hannover, Germany
Search for other works by this author on:
Thomas Klein,
Thomas Klein
From the *Tumor Immunology Program, Divison of Cellular Immunology, German Cancer Research Center, D-69120 Heidelberg, Germany; and the ‡Institute for Molecular Biology, Hannover Medical School, D-30625 Hannover, Germany
Search for other works by this author on:
Ulrich Rüther,
Ulrich Rüther
From the *Tumor Immunology Program, Divison of Cellular Immunology, German Cancer Research Center, D-69120 Heidelberg, Germany; and the ‡Institute for Molecular Biology, Hannover Medical School, D-30625 Hannover, Germany
Search for other works by this author on:
Bruno Kyewski
Bruno Kyewski
From the *Tumor Immunology Program, Divison of Cellular Immunology, German Cancer Research Center, D-69120 Heidelberg, Germany; and the ‡Institute for Molecular Biology, Hannover Medical School, D-30625 Hannover, Germany
Search for other works by this author on:
Ludger Klein
From the *Tumor Immunology Program, Divison of Cellular Immunology, German Cancer Research Center, D-69120 Heidelberg, Germany; and the ‡Institute for Molecular Biology, Hannover Medical School, D-30625 Hannover, Germany
Thomas Klein
From the *Tumor Immunology Program, Divison of Cellular Immunology, German Cancer Research Center, D-69120 Heidelberg, Germany; and the ‡Institute for Molecular Biology, Hannover Medical School, D-30625 Hannover, Germany
Ulrich Rüther
From the *Tumor Immunology Program, Divison of Cellular Immunology, German Cancer Research Center, D-69120 Heidelberg, Germany; and the ‡Institute for Molecular Biology, Hannover Medical School, D-30625 Hannover, Germany
Bruno Kyewski
From the *Tumor Immunology Program, Divison of Cellular Immunology, German Cancer Research Center, D-69120 Heidelberg, Germany; and the ‡Institute for Molecular Biology, Hannover Medical School, D-30625 Hannover, Germany
Address correspondence to Bruno A. Kyewski, Tumor Immunology Program, Division of Cellular Immunology, German Cancer Research Center, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany. Phone: 62-21-42-37-34; Fax: 62-21-42-37-02; E-mail: [email protected]
This study has been supported by the DFG (Ky 7/7-1), the German Cancer Research Center (B. Kyewski) and the Volkswagenstiftung (U. Rüther).
Received:
March 03 1998
Revision Received:
April 01 1998
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1998
J Exp Med (1998) 188 (1): 5–16.
Article history
Received:
March 03 1998
Revision Received:
April 01 1998
Citation
Ludger Klein, Thomas Klein, Ulrich Rüther, Bruno Kyewski; CD4 T Cell Tolerance to Human C-reactive Protein, an Inducible Serum Protein, Is Mediated by Medullary Thymic Epithelium . J Exp Med 1 July 1998; 188 (1): 5–16. doi: https://doi.org/10.1084/jem.188.1.5
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement